EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis

Stephan Lindsey, Eleftherios T Papoutsakis

Stem Cell Reviews and Reports · 2012-12 · 8 (4) · 1223-1235

DOI: 10.1007/s12015-012-9384-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 25.05.2012. Verfasst von Stephan Lindsey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical & Biomolecular Engineering, University of Delaware, 15 Innovation Way, Newark, DE 19711, USA. slindsey@udel.edu. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to its role as a toxicological signal mediator, the Aryl Hydrocarbon Receptor (AHR) is also a transcription factor known to regulate cellular responses to oxidative stress and inflammation through transcriptional regulation of molecules involved in the signaling of nucear factor-erythroid 2-related factor-2 (Nrf2), p53 (TRP53), retinoblastoma (RB1), and NFκB. Recent research suggests that AHR activation of these signaling pathways may provide the molecular basis for understanding AHR's evolving role in endogenous developmental functions during hematopoietic stem-cell maintenance and differentiation. Recent developments into the hematopoietic roles for AHR are reviewed, aiming to reconcile divergent findings as to the endogenous function of AHR in hematopoiesis. Potential mechanistic explanations for AHR's involvement in hematopoietic differentiation are discussed, focusing on its known role as a cell cycle mediator and its interactions with Hypoxia-inducible transcription factor-1 alpha (HIF1-α). Understanding the physiological mechanisms of AHR activation and signaling have far reaching implications ranging from explaining the action of various toxicological agents to providing novel ways to expand stem cell populations ex vivo for use in transplant therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBasic Helix-Loop-Helix ProteinsHematopoiesisHematopoietic Stem CellsHumansHypoxia-Inducible Factor 1, alpha SubunitNF-E2-Related Factor 2NF-kappa BReceptors, Aryl HydrocarbonRetinoblastoma ProteinSignal TransductionTumor Suppressor Protein p53

Substanzen

Basic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha SubunitNF-E2-Related Factor 2NF-kappa BReceptors, Aryl HydrocarbonRetinoblastoma ProteinTumor Suppressor Protein p53AHR protein, humanHIF1A protein, humanNFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Chemical & Biomolecular Engineering, University of Delaware, 15 Innovation Way, Newark, DE 19711, USA. slindsey@udel.edu

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Lindsey, S., & Papoutsakis, E. T. (2012). The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis. Stem Cell Reviews and Reports, 8(4), 1223-1235. https://doi.org/10.1007/s12015-012-9384-5

Vancouver

Lindsey S, Papoutsakis ET. The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis. Stem Cell Reviews and Reports. 2012;8(4):1223-1235. doi:10.1007/s12015-012-9384-5

BibTeX
@article{Lindsey2012,
  author = {Lindsey, Stephan and Papoutsakis, Eleftherios T},
  title = {The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis},
  journal = {Stem Cell Reviews and Reports},
  year = {2012},
  volume = {8},
  number = {4},
  pages = {1223--1235},
  doi = {10.1007/s12015-012-9384-5}
}
Kostenlos starten →